DK0413278T3 - Anvendelse af xanthinderivater mod mavesår - Google Patents

Anvendelse af xanthinderivater mod mavesår

Info

Publication number
DK0413278T3
DK0413278T3 DK90115456.7T DK90115456T DK0413278T3 DK 0413278 T3 DK0413278 T3 DK 0413278T3 DK 90115456 T DK90115456 T DK 90115456T DK 0413278 T3 DK0413278 T3 DK 0413278T3
Authority
DK
Denmark
Prior art keywords
peptic ulcer
xanthine derivatives
derivatives against
alkyl
against peptic
Prior art date
Application number
DK90115456.7T
Other languages
Danish (da)
English (en)
Inventor
Ulrich Dr Gebert
Toshizo Tanaka
Shoryo Hayashi
Yuko Morioka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0413278T3 publication Critical patent/DK0413278T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK90115456.7T 1989-08-16 1990-08-11 Anvendelse af xanthinderivater mod mavesår DK0413278T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21018789 1989-08-16

Publications (1)

Publication Number Publication Date
DK0413278T3 true DK0413278T3 (da) 1997-04-07

Family

ID=16585226

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115456.7T DK0413278T3 (da) 1989-08-16 1990-08-11 Anvendelse af xanthinderivater mod mavesår

Country Status (18)

Country Link
US (1) US5109003A (de)
EP (1) EP0413278B1 (de)
JP (1) JP2977242B2 (de)
KR (1) KR910004620A (de)
AT (1) ATE144900T1 (de)
AU (1) AU624987B2 (de)
CA (1) CA2023310A1 (de)
DD (1) DD298051A5 (de)
DE (1) DE69029069T2 (de)
DK (1) DK0413278T3 (de)
ES (1) ES2094132T3 (de)
GR (1) GR3021569T3 (de)
HU (1) HU207518B (de)
IE (1) IE902954A1 (de)
IL (1) IL95377A (de)
NZ (1) NZ234896A (de)
PT (1) PT95007A (de)
ZA (1) ZA906446B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IL106861A (en) * 1986-12-31 1997-02-18 Hoechst Roussel Pharma Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
JPH03163019A (ja) 1991-07-15
US5109003A (en) 1992-04-28
CA2023310A1 (en) 1991-02-17
DE69029069T2 (de) 1997-04-10
KR910004620A (ko) 1991-03-29
PT95007A (pt) 1991-04-18
NZ234896A (en) 1993-10-26
EP0413278A2 (de) 1991-02-20
GR3021569T3 (en) 1997-02-28
ATE144900T1 (de) 1996-11-15
HUT54688A (en) 1991-03-28
IE902954A1 (en) 1991-02-27
DE69029069D1 (de) 1996-12-12
ES2094132T3 (es) 1997-01-16
IL95377A (en) 1994-08-26
DD298051A5 (de) 1992-02-06
EP0413278B1 (de) 1996-11-06
HU905000D0 (en) 1991-01-28
AU624987B2 (en) 1992-06-25
EP0413278A3 (en) 1992-05-06
HU207518B (en) 1993-04-28
IL95377A0 (en) 1991-06-30
JP2977242B2 (ja) 1999-11-15
AU6101890A (en) 1991-02-21
ZA906446B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
FI860369A (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
DE68904792D1 (de) Biozide zusammensetzung.
DE3879258D1 (de) Praeparat gegen ulcus.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
ES2065994T3 (es) Beta-dicetonas substituidas.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
NO974462L (no) Forbindelse til anvendelse ved fremstilling av alkylderivater av trazodon med CNS-aktivitet
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.